In a 2‑day postpartum woman with type 2 diabetes who is breastfeeding and currently on insulin glargine (Lantus) 9 units with hyperglycemia (blood glucose ≈242 mg/dL) due to lack of carbohydrate coverage, should she be discharged on insulin glargine or metformin?

Discharge Medication for Postpartum Type 2 Diabetes with Hyperglycemia

She should be discharged on insulin (Lantus), not metformin alone, because her current blood glucose of 242 mg/dL indicates inadequate glycemic control that requires immediate insulin therapy, and breastfeeding is compatible with both insulin and metfortin. 1

Immediate Discharge Regimen

Insulin Therapy (Preferred)

• Continue Lantus at 9 units once daily and increase by 2–4 units every 3 days until fasting glucose reaches 80–130 mg/dL, as this dose is insufficient for her current hyperglycemia. 1, 2
• Add rapid-acting insulin (4 units before the largest meal) to address postprandial hyperglycemia, since her glucose of 242 mg/dL without carbohydrate coverage indicates both inadequate basal and prandial insulin. 1, 2
• Administer rapid-acting insulin 0–15 minutes before meals for optimal postprandial control. 1, 2

Metformin as Adjunctive Therapy

• Start or continue metformin 1000 mg twice daily (2000 mg total) in combination with insulin, as this reduces total insulin requirements by 20–30% and is safe during breastfeeding. 1
• Metformin is compatible with breastfeeding and can continue with glibenclamide even while nursing. 1

Rationale for Insulin Over Metformin Monotherapy

Severity of Hyperglycemia

• A blood glucose of 242 mg/dL represents severe hyperglycemia requiring immediate insulin therapy rather than waiting for metformin's delayed onset (days to weeks). 1
• Patients with type 2 diabetes and fasting glucose ≥180 mg/dL should receive insulin as first-line therapy. 1, 2

Postpartum Insulin Requirements

• After delivery, maternal insulin requirements fall rapidly to approximately 34% lower than prepregnancy levels, but this patient still requires insulin given her current hyperglycemia. 1
• Insulin sensitivity returns to prepregnancy levels over 1–2 weeks postpartum, necessitating close monitoring and dose adjustments. 1
• There is heightened risk of hypoglycemia during breastfeeding due to erratic sleep and eating schedules, requiring careful insulin titration. 1

Breastfeeding Considerations

• Breastfeeding is associated with improved postpartum glucose regulation and reduced fasting glucose by 3.7–7.4 mg/dL (0.2–0.4 mmol/L) in women with gestational diabetes. 3, 4, 5
• Women who breastfeed exclusively have mean glucose of 4.6 mmol/L compared to 4.9 mmol/L in those who do not exclusively breastfeed. 4
• Breastfeeding reduces the risk of progression to type 2 diabetes and should be strongly encouraged and supported. 3, 5

Insulin Titration Protocol

Basal Insulin (Lantus) Adjustment

• Increase Lantus by 4 units every 3 days if fasting glucose ≥180 mg/dL. 1, 2
• Increase Lantus by 2 units every 3 days if fasting glucose is 140–179 mg/dL. 1, 2
• Target fasting glucose: 80–130 mg/dL. 1, 2
• If hypoglycemia occurs (glucose <70 mg/dL), reduce the dose by 10–20% immediately. 1, 2

Prandial Insulin Titration

• Increase each meal dose by 1–2 units every 3 days based on 2-hour postprandial glucose readings. 1, 2
• Target postprandial glucose: <180 mg/dL. 1, 2

Critical Threshold

• When basal insulin approaches 0.5 units/kg/day without achieving targets, add or intensify prandial insulin rather than continuing basal escalation. 1, 2

Monitoring Requirements

Glucose Monitoring

• Check fasting glucose daily during titration to guide basal insulin adjustments. 1, 2
• Measure pre-meal glucose before each meal to calculate correction doses. 1, 2
• Obtain 2-hour postprandial glucose after meals to assess prandial insulin adequacy. 1, 2

Follow-Up Schedule

• Schedule follow-up within 1–2 weeks postdischarge to assess glucose control and adjust insulin doses. 1
• Recheck HbA1c at 4–12 weeks postpartum using a 75-g oral glucose tolerance test (OGTT) rather than HbA1c, as A1C may be persistently lowered by pregnancy. 1

Hypoglycemia Management

Prevention and Treatment

• Treat any glucose <70 mg/dL immediately with 15 g of fast-acting carbohydrate, recheck in 15 minutes, and repeat if needed. 1, 2
• Provide a glucagon emergency kit for severe hypoglycemia risk. 1
• Educate on hypoglycemia recognition, treatment, and the increased risk during breastfeeding. 1, 6

Patient Education Essentials

Insulin Administration

• Teach proper insulin injection technique and site rotation to prevent lipohypertrophy. 1, 6
• Provide instruction on self-titration of insulin doses based on glucose monitoring. 1, 6

Breastfeeding Support

• Emphasize that both insulin and metformin are safe during breastfeeding. 1
• Counsel on the metabolic benefits of breastfeeding for glucose control and diabetes prevention. 3, 4, 5
• Warn about increased hypoglycemia risk during breastfeeding and the need for frequent glucose monitoring. 1, 6

Sick-Day Management

• Continue insulin even if not eating, check glucose every 4 hours, and maintain hydration. 1, 6
• Check for ketones if glucose >300 mg/dL with nausea or vomiting. 1

Common Pitfalls to Avoid

• Do not delay insulin initiation when glucose is 242 mg/dL, as prolonged hyperglycemia increases complication risk. 1, 2
• Do not rely on metformin monotherapy for immediate glucose control in severe hyperglycemia, as its onset is too slow. 1
• Do not discontinue metformin when starting insulin unless contraindicated, as the combination provides superior control. 1, 2
• Never use sliding-scale insulin as monotherapy; scheduled basal-bolus therapy is required. 1
• Do not continue escalating basal insulin beyond 0.5 units/kg/day without addressing postprandial hyperglycemia. 1, 2

Expected Clinical Outcomes

• With properly implemented basal-bolus therapy combined with metformin, approximately 68% of patients achieve mean glucose <140 mg/dL. 1, 2
• Breastfeeding women with prior gestational diabetes who receive insulin therapy show reduced fasting glucose by 0.22 mmol/L compared to non-breastfeeding women. 4
• The combination of insulin and metformin reduces total insulin requirements and provides superior glycemic control compared to insulin alone. 1, 2